Psychedelic Drugs

New research suggests that psychedelics like LSD and psilocybin increase unusual visual phenomena, such as seeing with open eyes patterns or objects that are not actually present.

Low doses of MDMA may reduce challenging effects of LSD and psilocybin, increasing positive experiences like love and self-compassion, according to Scientific Reports. This supports the therapeutic potential of "candy flipping" and "hippy flipping."

MDMA-assisted therapy shows promise in enhancing emotional awareness and self-compassion in PTSD patients, areas typically unresponsive to conventional treatments.

New research in the European Journal of Psychotraumatology shows the therapeutic relationship's strength is key in MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD), indicating better outcomes with a stronger alliance.

A study on rats suggests that microdosing psilocybin could reduce stress-induced anhedonia and compulsive behaviors without causing anxiety or schizophrenia-like symptoms. This research offers insights into psilocybin's potential as a therapy for mental health disorders, though further human studies are...

New research sheds light on the relationship between the intensity of psychedelic experiences and mystical language used to describe these experiences, with both high and low intensity experiences being more likely to include such language. The study was published in...

A recent neuroimaging study shows psilocybin, found in magic mushrooms, significantly alters brain connectivity in alcohol-dependent rats. This mirrors effects seen in humans, offering new avenues for researching the therapeutic impact of psychedelics.

A pilot study investigating a group of adults visiting an ayahuasca retreat in Peru found significant reductions in their levels of inattention, hyperactivity, and impulsivity following their stay. These reductions occurred regardless of the duration of the retreat or the...

Scientists have discovered that rapid-acting antidepressants like ketamine, psilocybin, and scopolamine can alter negative mood biases in rodent models, a symptom common in depressive disorders. This breakthrough, published in Science Translational Medicine, suggests new approaches to treat Major Depressive Disorder...

A study published in Nature Medicine shows MDMA-assisted therapy significantly reduces symptoms in individuals with severe PTSD, offering promising results for those unresponsive to traditional treatments, and is well-tolerated with few side effects.

A new study provides evidence that the lingering effects of hallucinogenic drugs, known as Hallucinogen Persisting Perception Disorder (HPPD), are more common among users than previously understood.

Stanford researchers found that a combination of magnesium and ibogaine significantly reduced symptoms of PTSD, depression, and anxiety in veterans with traumatic brain injuries. The treatment also improved cognitive functions.

A study analyzed Reddit posts to investigate how psilocybin affects self-perception and recognition in mirror gazing, finding it tends to enhances positive self-perception without impairing self-recognition.

Recent psychedelic research shows promising results for mental illnesses and eating disorders, with surveys and reports indicating psilocybin-assisted therapy's potential. However, challenges in research methodology, patient safety concerns, and the need for cautious optimism highlight the gap between scientific evidence...